Distinctive IGH gene segment usage and minimal residual disease detection in infant acute lymphoblastic leukaemias-Reference-Cited by-同舟云学术

Distinctive IGH gene segment usage and minimal residual disease detection in infant acute lymphoblastic leukaemias

Published:2005-10 Issue:2 Volume:131 Page:185-192
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Li Aihong,Goldwasser Meredith A.,Zhou Jianbiao,Armstrong Scott A.,Wang Hongjun,Dalton Virginia,Fletcher Jonathan A.,Sallan Stephen E.,Silverman Lewis B.,Gribben John G.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2005.05754.x/fullpdf

Reference41 articles.

1. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

2. FLT3 mutations in childhood acute lymphoblastic leukemia

3. VH gene usage in humans: biased usage of the VH6 gene in immature B lymphoid cells

4. Biological and therapeutic aspects of infant leukemia

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy of high-risk infant acute lymphoblastic leukemia using blinatumomab and infusion of donor lymphocytes;Pediatric Hematology/Oncology and Immunopathology;2022-12-26

2. Comparison of minimal residual disease measurement by multicolour flow cytometry and PCR for fusion gene transcripts in infants with acute lymphoblastic leukaemia with KMT2A gene rearrangements;British Journal of Haematology;2021-12-30

3. Utilizing the prognostic impact of minimal residual disease in treatment decisions for pediatric acute lymphoblastic leukemia;Expert Review of Hematology;2021-09-02

4. Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol;Journal of Clinical Oncology;2021-02-20

5. Prognostic value of minimal residual disease measured by fusion‐gene transcript in infants with KMT2A ‐rearranged acute lymphoblastic leukaemia treated according to the MLL‐Baby protocol;British Journal of Haematology;2021-02-14